Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
21.12
+0.87 (4.30%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Castle Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -12.83 | -24.16 | 18.25 | -57.47 | -67.14 | -31.29 |
Depreciation & Amortization | 14.94 | 40.77 | 16 | 12.33 | 10.54 | 3.41 |
Stock-Based Compensation | 44.49 | 45.89 | 50.32 | 51.22 | 36.32 | 21.74 |
Other Adjustments | -12.96 | -11.76 | -5.57 | -5.08 | -21.37 | -8.74 |
Change in Receivables | 13.17 | 6.88 | -12.64 | -14.93 | -6.22 | -4.63 |
Changes in Inventories | -3.64 | -2.14 | -0.19 | -3.96 | -1.68 | 0.33 |
Changes in Accounts Payable | 5.66 | 3.08 | -4.37 | 5.71 | 0.58 | -0.18 |
Changes in Accrued Expenses | 3.74 | 6.6 | 3.93 | 6.73 | 7.53 | 8.49 |
Changes in Other Operating Activities | -4.3 | -0.81 | -0.85 | -0.17 | -0.22 | -8.11 |
Operating Cash Flow | 48.25 | 64.35 | 64.87 | -5.63 | -41.66 | -18.98 |
Operating Cash Flow Growth | -26.52% | -0.80% | - | - | - | - |
Capital Expenditures | -43.74 | -36.02 | -28.33 | -13.62 | -5.63 | -3.48 |
Sale of Property, Plant & Equipment | 0.04 | 0.05 | 0.02 | 0.01 | 0.2 | 0.01 |
Purchases of Investments | -195.42 | -194.28 | -205.73 | -189.08 | -134.69 | - |
Proceeds from Sale of Investments | 194.68 | 190.73 | 183.9 | 186.5 | - | - |
Payments for Business Acquisitions | -9.36 | -18.73 | - | - | -26.42 | -63.18 |
Other Investing Activities | - | -2.11 | - | - | - | - |
Investing Cash Flow | -63.74 | -60.37 | -50.14 | -16.18 | -166.55 | -66.66 |
Long-Term Debt Issued | - | - | 10 | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | - | 10 | - | - | - |
Issuance of Common Stock | 5.22 | 4.62 | 5 | 2.98 | 3.33 | 6.21 |
Repurchase of Common Stock | -15.74 | -11.66 | -8.76 | -5.13 | -1.69 | -0.78 |
Net Common Stock Issued (Repurchased) | -10.52 | -7.04 | -3.76 | -2.16 | 1.64 | 5.43 |
Other Financing Activities | -0.02 | 0.08 | -0.1 | -0.14 | -0.12 | -0.01 |
Financing Cash Flow | -10.44 | -6.96 | 6.14 | -2.3 | 1.52 | 5.42 |
Net Cash Flow | -25.93 | -2.98 | 20.87 | -24.11 | -206.69 | -80.22 |
Free Cash Flow | 4.52 | 28.33 | 36.54 | -19.25 | -47.29 | -22.47 |
Free Cash Flow Growth | -84.05% | -22.48% | - | - | - | - |
FCF Margin | 1.33% | 8.23% | 11.00% | -8.76% | -34.51% | -23.88% |
Free Cash Flow Per Share | 0.15 | 0.98 | 1.25 | -0.72 | -1.81 | -0.89 |
Levered Free Cash Flow | -49.7 | -12.83 | 14.43 | -50.46 | -56.02 | -48.28 |
Unlevered Free Cash Flow | -69.04 | -23.6 | -6.48 | -61.09 | -59.87 | -48.36 |